Mar. 06. 2020
Osaka, Japan – March 6, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) announced the launch dates with the below mentioned schedule for Tadalafil tablets (the branded product: Cialis®).
Tadalafil tablets are prescribed for the treatment of erectile dysfunction.
| Product Name | Launch Date |
|---|---|
| TADALAFIL Tablets 10 mg CI [SAWAI] | March 26, 2020 |
| TADALAFIL Tablets 20 mg CI [SAWAI] | March 19, 2020 |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.